Phreesia [PHR] vs Ge Healthcare [GEHC] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Phreesia Inc. wins in 6 metrics, Ge Healthcare Technologies Inc. wins in 14 metrics, with 0 ties. Ge Healthcare Technologies Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Phreesia Inc. | Ge Healthcare Technologies Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 229.25 | 15.92 | Ge Healthcare Technologies Inc. |
| Price-to-Book Ratio | 1.65 | 3.18 | Phreesia Inc. |
| Debt-to-Equity Ratio | 30.38 | 98.72 | Phreesia Inc. |
| PEG Ratio | -1.94 | -0.87 | Ge Healthcare Technologies Inc. |
| EV/EBITDA | 28.43 | 10.74 | Ge Healthcare Technologies Inc. |
| Profit Margin (TTM) | 0.48% | 10.10% | Ge Healthcare Technologies Inc. |
| Operating Margin (TTM) | 1.33% | 15.73% | Ge Healthcare Technologies Inc. |
| EBITDA Margin (TTM) | 1.33% | 15.73% | Ge Healthcare Technologies Inc. |
| Return on Equity | 0.77% | 22.38% | Ge Healthcare Technologies Inc. |
| Return on Assets (TTM) | 0.31% | 5.47% | Ge Healthcare Technologies Inc. |
| Free Cash Flow (TTM) | $54.42M | $1.51B | Ge Healthcare Technologies Inc. |
| Dividend Yield | N/A | 0.25% | N/A |
| 1-Year Return | -59.74% | -11.62% | Ge Healthcare Technologies Inc. |
| Price-to-Sales Ratio (TTM) | 1.16 | 1.60 | Phreesia Inc. |
| Enterprise Value | $587.51M | $39.12B | Ge Healthcare Technologies Inc. |
| EV/Revenue Ratio | 1.22 | 1.90 | Phreesia Inc. |
| Gross Profit Margin (TTM) | 68.21% | 39.68% | Phreesia Inc. |
| Revenue per Share (TTM) | $8 | $45 | Ge Healthcare Technologies Inc. |
| Earnings per Share (Diluted) | $0.04 | $4.55 | Ge Healthcare Technologies Inc. |
| Beta (Stock Volatility) | 0.86 | 1.31 | Phreesia Inc. |
| Short % of Float | 6.70% | 3.07% | Ge Healthcare Technologies Inc. |
Phreesia Inc. vs Ge Healthcare Technologies Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Phreesia Inc. | -6.85% | 5.70% | -0.21% | -21.99% | -52.65% | -40.80% |
| Ge Healthcare Technologies Inc. | 0.06% | -2.90% | 1.69% | -20.61% | -25.79% | -25.10% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Phreesia Inc. | -59.74% | -69.80% | -81.61% | -58.92% | -58.92% | -58.92% |
| Ge Healthcare Technologies Inc. | -11.62% | -22.05% | 9.87% | 9.87% | 9.87% | 9.87% |
Performance & Financial Health Analysis: Phreesia Inc. vs Ge Healthcare Technologies Inc.
| Metric | PHR | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $568.74M | $31.89B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 2,132,160 | 2,502,586 |
| 90 Day Avg. Volume | 2,487,373 | 3,405,145 |
| Last Close | $9.65 | $62.03 |
| 52 Week Range | $7.77 - $32.76 | $58.75 - $89.77 |
| % from 52W High | -70.54% | -30.90% |
| All-Time High | $81.59 (Feb 08, 2021) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -88.17% | -34.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.16% | 0.07% |
| Quarterly Earnings Growth | 0.16% | -0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.10% |
| Operating Margin (TTM) | 0.01% | 0.16% |
| Return on Equity (TTM) | 0.01% | 0.22% |
| Debt to Equity (MRQ) | 30.38 | 98.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.56 | $22.77 |
| Cash per Share (MRQ) | $1.19 | $9.86 |
| Operating Cash Flow (TTM) | $78.81M | $1.99B |
| Levered Free Cash Flow (TTM) | $55.70M | $1.69B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.25% |
| Last 12-Month Dividend | $0.00 | $0.20 |
Valuation & Enterprise Metrics Analysis: Phreesia Inc. vs Ge Healthcare Technologies Inc.
| Metric | PHR (Apr 21, 2026) | GEHC (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 229.25 | 15.92 |
| Forward P/E | 5.42 | 13.02 |
| PEG Ratio | -1.94 | -0.87 |
| Price to Sales (TTM) | 1.16 | 1.60 |
| Price to Book (MRQ) | 1.65 | 3.18 |
| Market Capitalization | ||
| Market Capitalization | $568.74M | $31.89B |
| Enterprise Value | $587.51M | $39.12B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.22 | 1.90 |
| Enterprise to EBITDA | 28.43 | 10.74 |
| Risk & Other Metrics | ||
| Beta | 0.86 | 1.31 |
| Book Value per Share (MRQ) | $5.56 | $22.77 |
Financial Statements Comparison: Phreesia Inc. vs Ge Healthcare Technologies Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PHR (2026) | GEHC (2025) |
|---|---|---|
| Revenue/Sales | 480.59M | 20.63B |
| Cost of Goods Sold | 154.12M | 12.38B |
| COGS % of Revenue | 32.1% | 60.0% |
| Gross Profit | 326.47M | 8.25B |
| Gross Margin | 67.9% | 40.0% |
| Research & Development | 121.48M | 1.26B |
| Operating Income (EBIT) | -6.61M | 2.76B |
| Operating Margin | -1.4% | 13.4% |
| EBITDA | 29.97M | 3.69B |
| EBITDA Margin | 6.2% | 17.9% |
| Pre-Tax Income | -8.94M | 2.77B |
| Pre-Tax Income % of Revenue | -1.9% | 13.4% |
| Income Tax | -11.25M | 614.00M |
| Income Tax % of Revenue | -2.3% | 3.0% |
| Net Income (Profit) | 2.31M | 2.15B |
| Profit Margin | 0.5% | 10.4% |
Balance Sheet & Liquidity Metrics
| Metric | PHR (2026) | GEHC (2025) |
|---|---|---|
| Cash & Equivalents | 73.83M | 4.49B |
| Total Current Assets | 279.84M | 12.50B |
| Total Current Assets % of Revenue | 58.2% | 60.6% |
| Total Current Liabilities | 183.24M | 9.11B |
| Total Current Liabilities % of Revenue | 38.1% | 44.1% |
| Long-Term Debt | 93.22M | 9.82B |
| Long-Term Debt % of Revenue | 19.4% | 47.6% |
| Total Shareholders Equity | 337.21M | 10.60B |
| Retained Earnings | -799.19M | 5.28B |
| Retained Earnings % of Revenue | -166.3% | 25.6% |
| Property, Plant & Equipment | 18.53M | 410.00M |
Cash Flow Statement Comparison
| Metric | PHR (2026) | GEHC (2025) |
|---|---|---|
| Operating Cash Flow | 95.42M | 3.02B |
| Operating Cash Flow % of Revenue | 19.9% | 14.6% |
| Capital Expenditures | -11.10M | -482.00M |
| Free Cash Flow | 54.42M | 1.51B |
| FCF Margin | 11.3% | 7.3% |
| Debt Repayment | -26.83M | -1.77B |
| Common Stock Repurchase | 0 | -200.00M |
Short Interest & Institutional Ownership Analysis
| Metric | PHR | GEHC |
|---|---|---|
| Shares Short | 3.91M | 12.36M |
| Short Ratio | 1.67 | 3.20 |
| Short % of Float | 6.70% | 3.07% |
| Shares Outstanding | 60.67M | 455.74M |
| Float Shares | 48.26M | 454.48M |
| % Held by Insiders | 4.72% | 0.35% |
| % Held by Institutions | 114.71% | 93.39% |
| % Held by Public | -19.43% | 6.26% |
Dividend Analysis & Yield Comparison: Phreesia Inc. vs Ge Healthcare Technologies Inc.
| Metric | PHR | GEHC |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $0.20 |
| Last 12-Month Dividend Yield | N/A | 0.25% |
| 3-Year Avg Annual Dividend | $0.00 | $0.15 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | $0.00 | $0.45 |
| Ex-Dividend Date | N/A | Apr 02, 2026 |